Company: WELNF
Filing Date: 2025-10-31
Form Type: PRE 14A
Source: 0001104659-25-104954
Chunk: 17

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-10-31
Form: PRE 14A
Chunk 17
---
 Ordinary Shares were issued and outstanding. As a result
of the June 2023 Extension and December 2023 Extension, and as provided in the current M&A, the Company had until December 13,
2024 to complete its initial business combination.

On December 11, 2024,
the Company held an extraordinary general meeting, at which its shareholders approved, among others, a proposal to extend the date by
which it would be required to consummate a business combination from December 13, 2024 to December 15, 2025 (or such earlier
date as determined by the Board) (the “December 2024 Extension”).

<div align='center'>11</div>

If the M&A Amendment
Proposals (which are conditioned on each other) are approved and implemented, the Termination Date will be extended as far as March 16,
2026 (or such earlier date as determined by the Board, in its sole discretion). If these proposals are approved and implemented, our Board
may elect, in its sole discretion, to wind up our operations on any date following the adoption of the M&A Amendments, in which case
we will liquidate the Trust Account to redeem all public shares and thereafter liquidate and dissolve in accordance with law. Our Board
believes that it is in the best interests of the shareholders to both continue the Company’s existence as currently permitted under
our M&A until the expiration of the Extension Period and to enable the Company to liquidate the Trust Account and dissolve in accordance
with law and to redeem all public shares following the adoption of the M&A Amendments at any time before or after the current Termination
Date, and prior to the end of the Extension Period. Therefore, the Board is submitting the proposals described in this proxy statement
for the shareholders to vote upon.

The Company will hold a separate
general meeting of its shareholders to approve the Business Combination (the “Business Combination Meeting”).

The Company believes that
it is in the best interests of the Company’s shareholders to continue the Company’s existence until the Extended Date in order
to allow the Company additional time to complete the Business Combination and is therefore holding this Meeting.

What is being voted on?

You are being asked to vote on the
following proposals:

(i) Proposal 1 — A
proposal to amend by special resolution (the “Extension Amendment”) the Company’s amended and restated memorandum
and articles of association as amended prior to the date hereof (the “M&A”) in the form